advertisement
Mori K 20
Showing records 1 to 20 | Display all abstracts from Mori K86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Maruyama Y
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Maruyama Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86316 Usefulness of data augmentation for visual field trend analyses in patients with glaucoma
Asaoka R; Murata H
British Journal of Ophthalmology 2020; 104: 1697-1703
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Ikeda Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Ikeda Y
British Journal of Ophthalmology 2021; 105: 169-173
86316 Usefulness of data augmentation for visual field trend analyses in patients with glaucoma
Matsuura M
British Journal of Ophthalmology 2020; 104: 1697-1703
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Mori K
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Mori K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshii K
British Journal of Ophthalmology 2021; 105: 169-173
86316 Usefulness of data augmentation for visual field trend analyses in patients with glaucoma
Fujino Y
British Journal of Ophthalmology 2020; 104: 1697-1703
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Yoshii K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86316 Usefulness of data augmentation for visual field trend analyses in patients with glaucoma
Miki A
British Journal of Ophthalmology 2020; 104: 1697-1703
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Ueno M
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Ueno M; Sotozono C
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86316 Usefulness of data augmentation for visual field trend analyses in patients with glaucoma
Tanito M
British Journal of Ophthalmology 2020; 104: 1697-1703
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshikawa H; Sotozono C
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Kinoshita S
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86316 Usefulness of data augmentation for visual field trend analyses in patients with glaucoma
Mizoue S
British Journal of Ophthalmology 2020; 104: 1697-1703
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Kinoshita S
British Journal of Ophthalmology 2021; 105: 169-173
86316 Usefulness of data augmentation for visual field trend analyses in patients with glaucoma
Mori K; Suzuki K; Yamashita T; Kashiwagi K; Shoji N
British Journal of Ophthalmology 2020; 104: 1697-1703
